Anti-proliferation effect and its mechanism of TGF-β1 on gastric carcinoma and drug-resistant gastric carcinoma cells
Ri-long PIAO,Zhu-hu LI,Zhen-hua LIN,Mei-Yu YIN
DOI: https://doi.org/10.16073/j.cnki.cjcpt.2009.07.008
2009-01-01
Abstract:OBJECTIVE: To investigate the proliferation effect and its mechanism of TGF-β1 on gastric carcinoma and drug resistant gastric carcinoma cells. METHODS: The cell survival inhibitory rates at 24 h, 48 h and 72 h, C-myc gene expression, and the telemerase activity were detected by using MTT, RT-PCR, and ELISA methods, respectively. RESULTS: In the TGF-β1 treatment group, the cell survival inhibitory rates at 24 h, 48 h and 72 h were (18.66±1.37)%, (21.19±1.55)% and (31.51±1.71)% on SNU-601 cells, and (38.90±2.56)%, (50.00±2.61)% and (50.38±1.86)% and on SNU-601/cis10 cells, respectively, and significantly increased compared with the control group, P = 0.000. RT-PCR assay showed TGF-β1 inhibited C-myc gene expression in the experiment group in a time-dependent manner, which showed a significant difference between the experimental and control groups, P<0.05. In addition, the telomerase activity assay showed TGF-β1 inhibited the telomerase activity in the experiment group in a time-dependent manner, which showed a significant difference between the experimental and control groups, and especially it had the inhibition effect on resistant gastric carcinoma cells, and there was no any activity of telomerase at 48 h and 72 h. There was a significant difference between gastric carcinoma cells and resistant gastric carcinoma cells, P<0.05. CONCLUSIONS: TGF-β1 could inhibit the proliferation of SNU-601 gastric carcinoma and SNU-601/cis10 drug resistant gastric carcinoma cells, and especially has the inhibition effect on the resistant gastric carcinoma cells. The inhibitory effect of TGF-β1 might be correlated with the C-myc gene expression and the activity of telomerase.